User: subbu Topic: Land Issues
Category: SEZs by State :: Gujarat
Last updated: Aug 16 2017 13:41 IST RSS 2.0
 
1 to 20 of 3,701    
Zydus Cadila gets USFDA nod for blood pressure drug 16.8.2017 ET: Pharma
With the latest approvals from the USFDA, the group now has more than 140 approvals and has so far filed over 300 abbreviated new drug applications.
Also found in: [+]
Adani Ports & SEZ net dips 14% in Q1 13.8.2017 Sify Finance
Adani Ports and Special Economic Zone (APSEZ) on Saturday reported a consolidated net profit of Rs 710 crore for the first quarter of 2017-18, registering 14 per cent decline from Rs 823 crore in the same period year ago.
Also found in: [+]
Singapore International Arbitration Centres opens office in GIFT IFSC 10.8.2017 Business Standard: News Now
In what could further facilitate overseas dispute resolution on Indian shores, the Singapore International Arbitration Centre (SIAC) has opened a second representative office in India at the Gujarat International Finance Tec-City (GIFT) International Financial Services Centre Zone (IFSC). The second office comes on the back of a This Memorandum of Agreement (MoA) entered into between SIAC and GIFT. Indian entities have been one of the largest users of SIAC's services, being consistently ranked amongst the top three foreign users of SIAC in the last five years, as well as recognised as top foreign user of SIAC in 2013, 2015 and 2016.According to Ajay Pandey, MD & Group CEO of GIFTCL, the SIAC office will provide neutral and independent dispute resolution platform for entities, thereby enabling them to undertake large international financial transactions from GIFT IFSC."GIFT companies will also start adopting SIAC's model clause as their preferred dispute resolution clause for ...
Also found in: [+]
Britannia churns aggressive capex plan 22.7.2017 Deccan Herald - Business
Biscuit maker Britannia Industries will look to spend Rs 350 crore on capital expenditure in 2017-18, a growth of 35% over the previous year, to grow its business. The company, which makes a wide range of biscuits and cookies among other products, is looking at creating more manufacturing capacities at Guwahati in Assam, Ranjangaon in Maharashtra and Mundra SEZ in Gujarat during 2017-18. Britannias investment in R&D (including a new R&D centre commissioned in FY17), is paying off handsomely both in terms of new product launches and potential entry into adjacencies, quoting the companys annual report, Motilal Oswal Securities Ltd, an investment advisory firm said. Distribution expansion has been massive, with its direct reach doubling over the past three years (overall reach of 4.7 million outlets at end-FY17, including 0.7 million outlets added over the past year). Britannia added eight new lines at five of its plants across south and west India in FY17. The biscuit maker is banking on low per capita ...
Also found in: [+]
CARE ratings for Indian debt instruments-Jul 17 17.7.2017 TOI: Intl Business
CARE-RATINGS/(DAILY):CARE ratings for Indian debt instruments-Jul 17
Also found in: [+]
Zydus gets USFDA nod to market Fingolimod capsules for sclerosis 14.7.2017 Business Standard: News Now
Drug will be produced at group's formulations manufacturing facility at pharma SEZ in Ahmedabad
Also found in: [+]
SEZ approvals to be cancelled if extension not sought after validity expiry 12.7.2017 All Economy & Policy Stories
The state governments in question have also been asked to recover duty exemptions from the SEZs
Also found in: [+]
No decision on Adani's Mundra plant transfer 12.7.2017 Business Standard: News Now
Adani Power needs lenders' go-ahead for hiving off the plant
Also found in: [+]
Zydus Cadila gets USFDA nod to market Doxazosin tablets 8.7.2017 ET: Pharma
The company has also received the tentative approval from the USFDA to market Lurasidone Hydrochloride Tablets in the strengths of 20 mg, 40 mg, 60 mg, 80 mg, and 120 mg, Zydus Cadila said.
Also found in: [+]
Zydus Cadila's anti-diabetic drug gets USFDA marketing nod 4.7.2017 ET: Pharma
The group now has nearly 120 approvals from the USFDA and so far filed 300 abbreviated new drug applications (ANDAs), Cadila Healthcare said.
Also found in: [+]
BRIEF-Cadila Healthcare says Zydus' combination drug for diabetes gets tentative FDA nod 4.7.2017 Sify Finance
July 4 (Reuters) - Cadila Healthcare Ltd:
Also found in: [+]
Cadila Healthcare gets stronger after board approves fund raising 27.6.2017 Business Standard: Front Page Headlines
Cadila Healthcare gained 0.83% to Rs 529.45 at 10:10 IST on BSE after the company said that its board approved in-principle to raise funds through various routes.
Also found in: [+]
BRIEF-Cadila Healthcare's Zydus gets final FDA nod for hep B drug 27.6.2017 Sify Finance
June 27 (Reuters) - Cadila Healthcare Ltd:
Also found in: [+]
Chinese firms inks deal with Adani, to invest $300 million in Gujarat 20.6.2017 ET: Power
An estimated investment of more than $300 million is expected to be made by East Hope Group in India, as part of the proposed cooperation between the two conglomerates.
Also found in: [+]
Chinese firms inks deal with Adani Group, to invest $300 mn in Gujarat 20.6.2017 Business Standard: Companies & Industry
East Hope Group, a 70 billion yuan company, is one of the largest corporate houses in China
Also found in: [+]
Chinese firms inks deal with Adani, to invest $300 mn in Gujarat 20.6.2017 All News-IANS Stories
India's Adani Group inked a deal with East Hope Group, one of China's largest companies, which will invest over $300 million to set up a manufacturing unit for solar power generation equipment in Gujarat.
Also found in: [+]
Top Chinese firm signs MoU with Adani group to invest $300 million 20.6.2017 ET: Engineering
The MoU proposes to set up manufacturing units in Mundra SEZ in Gujarat to produce solar power generation equipment, chemicals, aluminium and animal feed.
Also found in: [+]
Zydus Cadila gets USFDA nod for migraine drug 19.6.2017 All News-IANS Stories
Pharma major Zydus Cadila on Monday said it has received the final approval from the US Food and Drug Administration (FDA) to sell Eletriptan Hydrobromide tablets, used in the treatment of migraine.
Also found in: [+]
Zydus Cadila gets USFDA nod to market migraine drug 19.6.2017 ET: Pharma
Zydus Cadila has received the final approval from the USFDA to market Eletriptan Hydrobromide tablets, 20 mg (base) and 40 mg (base).
Also found in: [+]
Cadila Healthcare gets healthier after USFDA nod for migraine drug 19.6.2017 Top Stories
Cadila Healthcare rose 1.78% to Rs 534.75 at 12:00 IST on BSE after the company received the final approval from the US drug regulator to market Eletriptan Hydrobromide Tablets, 20 mg (base) and 40 mg (base).
Also found in: [+]
1 to 20 of 3,701